Draft:Mukund Chorghade

  • Comment: If he really is a Fellow of those societies then he passes WP:NPROF. However the sources do not verify that he is. Beyond that there is nothing to make him notable as yet. More proof is needed. Ldm1954 (talk) 09:09, 15 April 2026 (UTC)

Mukund S. Chorghade is an American chemist[1] known for his work in sterically protected and electronically activated metalloporphyrin catalysts, known as the Chorghade–Dolphin catalysts or chemosynthetic livers.[2][3]

He is an elected Fellow of the American Chemical Society, the American Association for the Advancement of Science, the Royal Society of Chemistry, the Royal Society of Medicine, the Royal Australian Chemical Institute and the American Institute of Chemists, the Indian Chemical Society.[4][5][6][failed verification]

Early life and education

Chorghade received his B.Sc. and M.Sc. degrees from the University of Poona.[7] He earned a Ph.D. in organic chemistry from Georgetown University, followed by postdoctoral research at the University of Virginia and Harvard University.[4] He later held visiting scientist positions at the University of British Columbia, Collège de France, Université Louis Pasteur, Cambridge, and Caltech.[8] In 2021, he was conferred completed an earned D.Sc. from by the University of Mumbai, and he has also received an honorary D.Sc. from the Datta Meghe Institute of Higher Education and Research.[6]

Career

He has directed research groups at The Dow Chemical Company, Abbott Laboratories, CytoMed, and Genzyme.[5] He has also served as Chief Scientific Officer for Chicago Discovery Solutions[9], AGN Biofuels, Empiriko, and Apinovo.[4]

Chorghade founded THINQ Pharma[10][11] and Ayurvidya Healthcare Innovations, through which he has advised pharmaceutical and biopharmaceutical companies on synthetic and medicinal chemistry, technology transfer, regulatory compliance, and process development.[12]

He has held adjunct or visiting roles at Harvard University, MIT, Caltech, Princeton University, Rutgers University, Northeastern University, Northwestern University, the University of Chicago, Boston College, Cambridge, Strathclyde, and the Institute of Chemical Technology in Mumbai.[13][5]

Research

Chorghade developed sterically protected, electronically activated metalloporphyrin catalysts with David Dolphin, incorporating extensive halogenation to improve oxidative stability and catalytic efficiency.[14][15]These biomimetic systems increased catalytic turnover and enabled predictive drug metabolism and late-stage oxidation reactions.[5]

References

  1. ^ Ashok Kumar, Palazhi. "Ayurveda—a blessing, but ignorance and apathy betrayed Indians, says senior scientist". Metro India. Retrieved 2026-04-13.
  2. ^ Lowe, Derek. "How drugs get to market". Chemistry World. Retrieved 2026-04-13.
  3. ^ Logan, Aaron. "An End to Animal Testing for Drug Discovery?". Lab Manager. American Chemical Society.
  4. ^ a b c "For president-elect: Mukund S. Chorghade". Chemical & Engineering News. 2025-01-21. Retrieved 2026-04-13.
  5. ^ a b c d Liebman, Michael (2016-12-15). "Translational Chemical Biology: Gap assessment for advancing drug discovery, development and precision medicine". Drug Discovery World (DDW). Retrieved 2026-04-13.
  6. ^ a b "Candidate Q&A: Mukund Chorghade". acsycc.org. Retrieved 2026-04-13.
  7. ^ "Mukund S. Chorghade". Empiriko. Retrieved 2026-04-13.
  8. ^ "A Talk by Dr. Mukund S. Chorghade" (PDF). Indian Institute of Science Education and Research, Berhampur.
  9. ^ "CAREER SYMPOSIUM 2016". Northeastern Section | American Chemical Society. Retrieved 2026-04-13.
  10. ^ Nayak, Manojranjan (2024-02-11). "SOA university to collaborate with US firm for natural medicines". The New Indian Express. Retrieved 2026-04-13.
  11. ^ SERVICE, ROBERT F. "Billion-dollar project would synthesize hundreds of thousands of molecules in search of new medicines". AAAS. Retrieved 2026-04-13.
  12. ^ "Indian Pharma Industry: Developing a conducive ecosystem". www.indianpharmapost.com. Retrieved 2026-04-13.
  13. ^ "Mukund Chorghade is a serial entrepreneur and Founder, President, and Chief Scientific Officer, THINQ Pharma and Ayurvidya Healthcare Innovations" (PDF). Sigma Xi.
  14. ^ Karunaratne, Veranja; Dolphin, David (1999-06-29). "ChemInform Abstract: Oxidation of 2‐Methylpyrroles with Perchlorinated Iron(III) Metalloporphyrin Catalysts: A Versatile Synthesis of Symmetric and Asymmetric Dipyrromethanes". ChemInform. 30 (26). doi:10.1002/chin.199926053. ISSN 0931-7597.
  15. ^ Chorghade, Mukund (2025-10-11). "13) Chorghade-Pure and Applied Chemistry.pdf". Pure & Appl. Chem.
This page will be placed in the following categories if it is moved to the article namespace.
Categories:

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.